Suppr超能文献

叉头结构后接无序尾巴:FOXO3a的内在无序区域。

Forkhead followed by disordered tail: The intrinsically disordered regions of FOXO3a.

作者信息

Wang Feng, Marshall Christopher B, Ikura Mitsuhiko

机构信息

The Campbell Family Cancer Research Institute, Princess Margaret Cancer Center, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Present affiliation: Department of Biochemistry; Vanderbilt University School of Medicine; Nashville, TN USA.

The Campbell Family Cancer Research Institute, Princess Margaret Cancer Center, Department of Medical Biophysics, University of Toronto , Toronto, Ontario, Canada.

出版信息

Intrinsically Disord Proteins. 2015 Jun 3;3(1):e1056906. doi: 10.1080/21690707.2015.1056906. eCollection 2015.

Abstract

Forkhead box Class O is one of 19 subfamilies of the Forkhead box family, comprising 4 human transcription factors: FOXO1, FOXO3a, FOXO4, and FOXO6, which are involved in many crucial cellular processes. FOXO3a is a tumor suppressor involved in multiple physiological and pathological processes, and plays essential roles in metabolism, cell cycle arrest, DNA repair, and apoptosis. In its role as a transcription factor, the FOXO3a binds a consensus Forkhead response element DNA sequence, and recruits transcriptional coactivators to activate gene transcription. FOXO3a has additional functions, such as regulating p53-mediated apoptosis and activating kinase ATM. With the exception of the structured DNA-binding forkhead domain, most of the FOXO3a sequence comprises intrinsically disordered regions (IDRs), including 3 regions (CR1-3) that are conserved within the FOXO subfamily. Numerous studies have demonstrated that these IDRs directly mediate many of the diverse functions of FOXO3a. These regions contain post-translational modification and protein-protein interaction sites that integrate upstream signals to maintain homeostasis. Thus, the FOXO3a IDRs are emerging as key mediators of diverse regulatory processes, and represent an important target for the future development of therapeutics for FOXO3a-related diseases.

摘要

叉头框O类是叉头框家族19个亚家族之一,包含4种人类转录因子:FOXO1、FOXO3a、FOXO4和FOXO6,它们参与许多关键的细胞过程。FOXO3a是一种肿瘤抑制因子,参与多种生理和病理过程,在代谢、细胞周期阻滞、DNA修复和细胞凋亡中发挥重要作用。作为转录因子,FOXO3a结合共有叉头反应元件DNA序列,并招募转录共激活因子来激活基因转录。FOXO3a还有其他功能,如调节p53介导的细胞凋亡和激活激酶ATM。除了结构化的DNA结合叉头域外,FOXO3a的大部分序列包含内在无序区域(IDR),包括FOXO亚家族内保守的3个区域(CR1-3)。大量研究表明,这些IDR直接介导FOXO3a的许多不同功能。这些区域包含翻译后修饰和蛋白质-蛋白质相互作用位点,整合上游信号以维持体内平衡。因此,FOXO3a的IDR正在成为多种调节过程的关键介质,并代表了未来开发FOXO3a相关疾病治疗方法的重要靶点。

相似文献

1
Forkhead followed by disordered tail: The intrinsically disordered regions of FOXO3a.
Intrinsically Disord Proteins. 2015 Jun 3;3(1):e1056906. doi: 10.1080/21690707.2015.1056906. eCollection 2015.
2
4
Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53.
J Mol Biol. 2008 Dec 19;384(3):590-603. doi: 10.1016/j.jmb.2008.09.025. Epub 2008 Sep 18.
5
Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.
Biol Psychiatry. 2009 Jan 15;65(2):150-9. doi: 10.1016/j.biopsych.2008.08.005. Epub 2008 Sep 27.
6
FoxO3a and disease progression.
World J Biol Chem. 2014 Aug 26;5(3):346-54. doi: 10.4331/wjbc.v5.i3.346.
7
Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases.
Oncogene. 2003 Jul 17;22(29):4557-68. doi: 10.1038/sj.onc.1206778.
8
Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
Mol Cell Biol. 2007 Jul;27(13):4917-30. doi: 10.1128/MCB.01789-06. Epub 2007 Apr 23.
10
Dynamic FoxO transcription factors.
J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87. doi: 10.1242/jcs.001222.

引用本文的文献

1
c-Myc and FOXO3a-The Everlasting Decision Between Neural Regeneration and Degeneration.
Int J Mol Sci. 2024 Nov 24;25(23):12621. doi: 10.3390/ijms252312621.
2
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders.
Drugs. 2024 May;84(5):491-501. doi: 10.1007/s40265-024-02021-8. Epub 2024 Apr 17.
3
Forkhead box O proteins: steering the course of stem cell fate.
Cell Regen. 2024 Mar 11;13(1):7. doi: 10.1186/s13619-024-00190-1.
4
FOXO family isoforms.
Cell Death Dis. 2023 Oct 27;14(10):702. doi: 10.1038/s41419-023-06177-1.
5
Role of FOXO3a Transcription Factor in the Regulation of Liver Oxidative Injury.
Antioxidants (Basel). 2022 Dec 16;11(12):2478. doi: 10.3390/antiox11122478.
7
FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.
Protein Sci. 2022 May;31(5):e4287. doi: 10.1002/pro.4287.
8
FOXOs: masters of the equilibrium.
FEBS J. 2022 Dec;289(24):7918-7939. doi: 10.1111/febs.16221. Epub 2021 Oct 15.
10
Therapeutic strategies targeting FOXO transcription factors.
Nat Rev Drug Discov. 2021 Jan;20(1):21-38. doi: 10.1038/s41573-020-0088-2. Epub 2020 Nov 10.

本文引用的文献

1
Binding cavities and druggability of intrinsically disordered proteins.
Protein Sci. 2015 May;24(5):688-705. doi: 10.1002/pro.2641. Epub 2015 Feb 24.
2
Intrinsically disordered proteins in cellular signalling and regulation.
Nat Rev Mol Cell Biol. 2015 Jan;16(1):18-29. doi: 10.1038/nrm3920.
3
Interplay between partner and ligand facilitates the folding and binding of an intrinsically disordered protein.
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15420-5. doi: 10.1073/pnas.1409122111. Epub 2014 Oct 13.
4
FoxO3a and disease progression.
World J Biol Chem. 2014 Aug 26;5(3):346-54. doi: 10.4331/wjbc.v5.i3.346.
5
FOXO transcription factors: their clinical significance and regulation.
Biomed Res Int. 2014;2014:925350. doi: 10.1155/2014/925350. Epub 2014 Apr 3.
6
Distinguishing induced fit from conformational selection.
Biophys Chem. 2014 May;189:33-9. doi: 10.1016/j.bpc.2014.03.003. Epub 2014 Apr 1.
7
Intrinsically disordered proteins and intrinsically disordered protein regions.
Annu Rev Biochem. 2014;83:553-84. doi: 10.1146/annurev-biochem-072711-164947. Epub 2014 Mar 5.
8
FoxO proteins: regulation and molecular targets in liver cancer.
Curr Med Chem. 2014 Apr;21(10):1231-46. doi: 10.2174/0929867321666131228205703.
9
Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
Oncogene. 2014 Aug 14;33(33):4213-25. doi: 10.1038/onc.2013.384. Epub 2013 Sep 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验